Community pharmacy is finally getting access to the summary care records – the GPs’ medical records of patients. This will enable pharmacy to assist in providing advanced and enhanced services for their patients, and will save time and cost and improve accuracy. The roll-out is starting in November but will probably not be completed until […]
The Off-Patent Drugs Bill has been guillotined in its second reading in the House of Commons after it did not have Government support. Introduced by an MP as a Private Members Bill, it would have sought to enable pharma to obtain a new licence for medicines that were no longer on patent where there was […]
An on-going shortage in skills of candidates for senior roles is leading to dangers in the UK’s standing in innovation in pharma. This depressing analysis has come from none other than the Association of the British Pharmaceutical Industry, the body representing big pharma in the UK. Pharma businesses are being forced to look abroad […]
Seven pharma businesses are in the top 100 for innovation, according to Thomson Reuters. The seven are Johnson & Johnson, Novartis, Roche, Abbott, Bayer, Bristol-Myers Squibb and Boehringer Ingelheim.
The business intelligence company’s report says: “As genomics drives the era of precision medicine and more and more therapies are being developed to specifically […]